These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 36310874)
1. A case of COVID-19-associated rhino-orbito-cerebral mucormycosis caused by Erami M; Mirhendi H; Momen-Heravi M; Hezaveh SJH; Ahsaniarani AH; Sabet SS; Aboutalebian S Front Cell Infect Microbiol; 2022; 12():898477. PubMed ID: 36310874 [TBL] [Abstract][Full Text] [Related]
2. Rhino-orbital mucormycosis due to Apophysomyces ossiformis in a patient with diabetes mellitus: a case report. Martínez-Herrera E; Frías-De-León MG; Julián-Castrejón A; Cruz-Benítez L; Xicohtencatl-Cortes J; Hernández-Castro R BMC Infect Dis; 2020 Aug; 20(1):614. PubMed ID: 32811466 [TBL] [Abstract][Full Text] [Related]
3. An interesting report of COVID-19 associated mucormycosis (CAM) cases by two different species of Mucorales. Kaur H; Kanaujia R; Nayak G; Ramavat AS; Patro S; Ghosh A; Chakrabarti A; Rudramurthy SM Indian J Med Microbiol; 2024; 50():100656. PubMed ID: 38925278 [TBL] [Abstract][Full Text] [Related]
4. Apophysomyces variabilis as an emerging pathogen in Mainland China. Li XY; Wang SJ; Huang GM; Zheng DY; Al-Odaini N; Pan KS; Zheng YQ; Cao CW Mycoses; 2023 Sep; 66(9):795-800. PubMed ID: 37226871 [TBL] [Abstract][Full Text] [Related]
5. A case of COVID-19-associated mucormycosis due to Lichtheimia ramosa. Aboutalebian S; Erami M; Momen-Heravi M; Charsizadeh A; Hezaveh SJH; Matini AH; Ahsaniarani AH; Fakhrehi M; Mirhendi H J Clin Lab Anal; 2023 Apr; 37(8):e24895. PubMed ID: 37183276 [TBL] [Abstract][Full Text] [Related]
6. Chronic orbital and calvarial fungal infection with Apophysomyces variabilis in an immunocompetent patient. Wolkow N; Jakobiec FA; Stagner AM; Cunnane ME; Piantadosi AL; Basgoz N; Lefebvre D Surv Ophthalmol; 2017; 62(1):70-82. PubMed ID: 27256687 [TBL] [Abstract][Full Text] [Related]
8. Finegoldia magna and Mucorales molds co-infection in a severe case of SARS-CoV-2 disease. Hristova R; Vlahova A; Christova M; Stamatov K; Stanimirov P J Infect Dev Ctries; 2023 Sep; 17(9):1231-1236. PubMed ID: 37824356 [TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis. Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140 [TBL] [Abstract][Full Text] [Related]
10. Fatal renal mucormycosis with Rashid S; Ben Abid F; Babu S; Christner M; Alobaidly A; Al Ansari AAA; Akhtar M Aging Male; 2020 Dec; 23(5):746-749. PubMed ID: 30879364 [TBL] [Abstract][Full Text] [Related]
11. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital. Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754 [TBL] [Abstract][Full Text] [Related]
12. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus. Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273 [TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous mucormycosis produced by the new species Apophysomyces mexicanus. Bonifaz A; Stchigel AM; Guarro J; Guevara E; Pintos L; Sanchis M; Cano-Lira JF J Clin Microbiol; 2014 Dec; 52(12):4428-31. PubMed ID: 25297328 [TBL] [Abstract][Full Text] [Related]
14. Apophysomyces variabilis, an emerging and worrisome cause of primary cutaneous necrotizing infections in India. Chander J; Singla N; Kaur M; Punia RPS; Attri AK; Alastruey-Izquierdo A; Stchigel A; Cano-Lira JF; Guarro J J Mycol Med; 2021 Dec; 31(4):101197. PubMed ID: 34454304 [TBL] [Abstract][Full Text] [Related]
15. A prospective study of mucormycosis in north India: experience from a tertiary care hospital. Bala K; Chander J; Handa U; Punia RS; Attri AK Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran. Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164 [TBL] [Abstract][Full Text] [Related]
18. Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19. Munhoz SD; Lellis RF; Reis APC; Del Negro GMB; Sousa MGT; Veasey JV An Bras Dermatol; 2022; 97(4):501-504. PubMed ID: 35691738 [TBL] [Abstract][Full Text] [Related]
19. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review. Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498 [TBL] [Abstract][Full Text] [Related]
20. COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review. Balushi AA; Ajmi AA; Sinani QA; Menon V; Berieki ZA; Shezawi AA; Azri SA; Rashdi AA; Jardani AA; Baluki TA; Ghaithi SA; Reesi AA; Al-Za'abi AT; Al' Balushi MA; Maqbali TA Int J Infect Dis; 2022 Aug; 121():203-210. PubMed ID: 35533833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]